10 Sources of evidence considered by the committee

10 Sources of evidence considered by the committee

The diagnostics assessment report was prepared by Southampton Health Technology Assessments Centre.

  • Frampton G, Jones J, Payne L, et al. Placental growth factor (alone or in combination with soluble fms‑like tyrosine kinase 1) as an aid to the assessment of women with suspected pre‑eclampsia: systematic review and economic analysis. September 2015.

Registered stakeholders

The following organisations accepted the invitation to participate in this assessment as registered stakeholders. They were invited to attend the scoping workshop and to comment on the diagnostics assessment report and the diagnostics consultation documents.


  • Alere International Ltd

  • Perkin Elmer LAS UK

  • Roche Diagnostics Ltd

  • Siemens

  • Thermo Fisher Scientific

Professional/specialist and patient/carer groups:

  • Action on Pre‑eclampsia (APEC)

  • Birth Trauma Association

  • British Maternal and Fetal Medicine Society

  • Institute of Biomedical Science

  • National Childbirth Trust (NCT)

  • Royal College of Nursing

  • Royal College of Physicians

  • Sands (Stillbirth and neonatal death charity)

  • The Multiple Births Foundation

  • Royal College of Pathologists


  • Department of Health

  • Healthcare Improvement Scotland

  • NHS England

  • Welsh Government

  • National Institute for Health and Care Excellence (NICE)